glp 1 tirzepatide zepbound Decoding GLP-1 Weight Loss Medications Researchers move closer to matching

INTERNATIONAL ROUNDUP (PharmaTimes, March 9-14) Regulatory Approvals: MHRA approved deuruxolitinib for severe alopecia areata NHS to offer fezolinetant for menopause hot flushes Clinical Trials: Aplagon dosed first patient in phase 2a peripheral arterial disease trial UCB reported bimekizumab superiority in psoriatic arthritis Kainova reported positive phase 1 data for DT-9081 in advanced solid tumours EnteroBiotix completed enrolment for EBX-102-02 trial in microbiome therapy Industry Appointments: Dr Michelle Morrow appointed CSO at Nucleome Dr Klaas Zuideveld named CEO at TECregen Rebecca Simmons appointed COO at Qureight KEY DATA POINTS SUMMARY Metric Value GLP-1 sales (MAT Feb 2026) 1,446 crore (177%) Stranded containers 40,000-45,000 Export cargo affected $1-1.5 billion War surcharge per container $3,000-5,000 Glycerin price increase 64% (Dec-Mar) Paracetamol API increase 26% (Dec-Mar) Polypropylene price increase 55/kg (since Dec) Universal NutriScience valuation 3,000 crore API exports (FY25) 41,500 crore API imports (FY25) 39,215 crore ABOUT THE INDIAN PHARMACEUTICAL INDUSTRY India is the "pharmacy of the world," supplying over 60% of global vaccine demand and 40% of generic medicines in the US

Platform-level subscription billing removes the app-compatibility risk that breaks when high-risk processors are involved

Tirzepatide mostly causes gastrointestinal side effects, including nausea, vomiting, and bloating

Understanding what data is coming helps researchers make informed decisions about starting, continuing, or modifying their protocols

No, there are no generic versions of either drug available

As regulations become more up-to-date, expanding the market to Asian countries like Vietnam and other new Southeast Asian markets can help it grow